Connect with us

Buyers Speak

Keeping India Healthy

Sterling Accuris Diagnostics is one of the fastest-growing pathology laboratory chains of India. In modern times, it is significant to focus more on prevention of diseases. Thus, preventive diagnosis is of utmost importance. On the other hand, accurate pathology diagnosis is essential to ensure the most effective treatment.

Keeping this in mind, Sterling Accuris Diagnostics came into existence with a singular mission of setting higher standards in diagnostics healthcare, in the year 2015. The well-known hospital of Gujarat – Sterling Hospitals – introduced Sterling Accuris Diagnostics. Within a short span of time, NABL and CAP-accredited Sterling Accuris Diagnostics has emerged as the most comprehensive and one of the fastest-growing pathology laboratory chains in India, providing reliable and dependable services to individuals, hospitals, and corporates.

Micronutrients play an important role in the proper growth and development of human body and its deficiency affects the health, contributing to low productivity and vicious cycle of malnutrition, underdevelopment as well as poverty. We as a part of diagnostic industry need to focus more on preventive checks for nutrition, especially in children and expectant and nursing mothers, for better future of India.

Cardiovascular diseases (CVDs) are the number one cause of deaths globally: more people die annually from CVDs than from any other cause. People with cardiovascular disease or those who are at high cardiovascular risk need early detection and management, using counselling and medicines, as appropriate. Our one-touch approach (with mobile application and website booking) of health packages will help in detecting all diabetes, CHD, and other diseases much sooner and before symptoms appear.

The molecular diagnostics tests are the most rapidly growing segment of the IVD industry. The next 10 years will witness significant developments in automation, as well as introduction of a wide range of new products that will require innovative approaches. The growth of clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. High demand of molecular tests for infectious diseases, forensic testing, cancer, paternity testing/HLA typing, and genetic diseases will keep diagnostic laboratories busy in development of newer tests. Our vision as a medical diagnostics industry will move toward a more targeted and personalized diagnosis with molecular tests.

Today, treatment for a growing number of infections, such as pneumonia, tuberculosis, septicemia and gonorrhea has become difficult and at times impossible because antibiotics are losing their effectiveness. We are also seeing the re-emergence of certain diseases (tuberculosis, for example) due to resistance to antibiotics.

New antibiotics are in development, but none of them is considered to be effective against the most resistant bacteria. It will take five to ten years before these new compounds become available.

Healthcare-associated infections are contracted by patients during the course of their treatment. HAIs are caused by microorganisms, such as bacteria, viruses, and fungi. Their development is facilitated by the severity of an underlying illness, the vulnerability of the patient (immunocompromised patients, premature babies, transplant recipients, elderly patients, and the like) as well as invasive medical procedures. Recent syndrome approach, which uses a single test for all the microorganisms suspected of causing an infectious disease, brings an innovative response to the problem of diagnosing infectious diseases. It saves time when the disease is diagnosed and allows the patient to begin treatment sooner. Our focus is on technology that uses a single test for the simultaneous detection of bacteria, viruses, fungi, or parasites that can cause an infectious disease, delivering fast result. Our microbiology tests vision is to make availability of sensitivity tests and identification of resistance bacteria as early as possible and making aware of resistance in form of CMEs and literatures to clinicians and ground root medical faculties.

Sterling Accuris Diagnostics is dedicated to provide quality service with an expert team of pathologists that embraces the responsibility of keeping India healthy.

Copyright © 2024 Medical Buyer

error: Content is protected !!